Tilray Brands (NASDAQ: TLRY)
Tilray Brands Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Tilray Brands Company Info
Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.
News & Analysis
3 Reasons Tilray Brands Investors Shouldn't Assume U.S. Marijuana Legalization Would Fix the Stock's Problems
Tilray Brands has been a bad buy in recent years, and that could remain the case for the foreseeable future.
Tilray Brands Missed on Revenue in Q3, but This Is the More Concerning Number for Investors
A company's cash position could help indicate whether a stock offering is on the horizon.
Why Tilray Brands Stock Fell 26.9% This Week
The cannabis lifestyle products company announced mixed results and lowered its full-year outlook.
Why Marijuana Stocks Got Burnt Today
If even Tilray can't make money from marijuana, what hope does any company have?
Why Tilray Brands Stock Just Crashed 21.5%
Tilray broke a promise. Now investors are breaking up with the company.
Why Tilray Stock Popped Today
Support for pot legalization -- or at least the mechanics behind it -- continues to be strong in the U.S.
Is Tilray Brands Stock a Millionaire Maker?
You'll need to be patient to gain the most from this investment.
Why Tilray, Cronos, and Canopy Growth Stocks All Popped Today
Two of these three cannabis stocks will benefit most from today's marijuana news.
Valuation
Earnings Transcripts
Tilray Brands (TLRY) Q3 2024 Earnings Call Transcript
TLRY earnings call for the period ending March 31, 2024.
Tilray Brands (TLRY) Q2 2024 Earnings Call Transcript
TLRY earnings call for the period ending December 31, 2023.
Tilray Brands (TLRY) Q1 2024 Earnings Call Transcript
TLRY earnings call for the period ending September 30, 2023.
Tilray Brands (TLRY) Q4 2023 Earnings Call Transcript
TLRY earnings call for the period ending June 30, 2023.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.